PBYI Stock Nosedives: Puma Biotechnology’s Nerlynx Revenue Falls
PBYI stock is the biggest loser in the biotech sector after Puma Biotechnology Inc. (NASDAQ:PBYI) reported disappointing revenue for its only commercial product, Nerlynx. Nevertheless, the company posted improved loss and revenue for the fiscal ... [Read]
BioTime Stock: “Buy” Ratings Abound, Should You Take Note?
BioTime stock is currently selling for $1.18 USD on the NYSE American exchange. At the time of writing, shares are down nearly 5%. Despite a rough few trading days, BTX stock has a consensus rating ... [Read]